Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro-oesophageal junction cancers

Histopathology

Volumn 56, Issue 7, 2010, Pages 893-899

  Brown, Matthew ^a   Sillah, Karim ^a,b   Griffiths, Ewen A ^c   Swindell, Ric ^b   West, Catherine M ^b   Page, Richard D ^d   Welch, Ian M ^a   Pritchard, Susan A ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c FURNESS GENERAL HOSPITAL   (United Kingdom)

^d LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

Gastro oesophageal cancer; Host inflammatory response; Oesophageal cancer; Tumour budding

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORPHOLOGY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HOST; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TUMOUR BUDDING; ADENOCARCINOMA; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; ESOPHAGUS TUMOR; INFLAMMATION; KAPLAN MEIER METHOD; LOWER ESOPHAGUS SPHINCTER; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; INFLAMMATION; KAPLAN-MEIERS ESTIMATE; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; KAPLAN-MEIER ESTIMATE;

EID: 77953226130     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03559.x     Document Type: Article

References (18)

1. Parkin DM, Bray F, Ferlay J et al. Global cancer statistics 2002. CA Cancer J. Clin. 2005 55 74 108.
2. Lepage C, Rachet B, Jooste V et al. Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am. J. Gastroenterol. 2008 103 2694 2699.
3. Keighley MR. Gastrointestinal cancers in Europe. Aliment. Pharmacol. Ther. 2003 18 7 30.
4. Mapstone N. Dataset for the histological reporting of oesophageal carcinoma, 2nd edn. Standards and Datasets for Reporting Cancers.
5. Gabbert H. Mechanisms of tumor invasion: evidence from in vivo observations. Cancer Metastasis Rev. 1985 4 293 309.
6. Prall F. Tumour budding in colorectal carcinoma. Histopathology 2007 50 151 162.
7. Roh MS, Lee JI, Choi PJ. Tumour budding as a useful prognostic marker in esophageal squamous cell carcinoma. Dis. Esophagus 2004 17 333 337.
8. Koike M, Kodera Y, Itoh Y et al. Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor. Ann. Surg. Oncol. 2008 15 1977 1982.
9. Gabbert H, Meier S, Gerharz CD et al. Tumor-cell dissociation at the invasion front: a new prognostic parameter in gastric cancer patients. Int. J. Cancer 1992 50 202 207.
10. Ma Y, Xian M, Li J et al. Interrelations of clinicopathological variables, local immune response and prognosis in esophageal squamous cell carcinoma. APMIS 1999 107 514 522.
11. Ikeguchi M, Saito H, Katano K et al. Correlation between the lymphocytic infiltration of tumors and the proliferative activity of cancer cells from surgically treated esophageal carcinoma. Oncology 1997 54 311 317.
12. Cho Y, Miyamoto M, Kato K et al. CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma. Cancer Res. 2003 63 1555 1559.
13. Sadanaga N, Kuwano H, Watanabe M et al. Local immune response to tumor invasion in esophageal squamous cell carcinoma. The expression of human leukocyte antigen-DR and lymphocyte infiltration. Cancer 1994 74 586 591.
14. Sobin LH, Whittekind Ch. UICC TNM classification of malignant tumours, 6th edn.
15. Hase K, Shatney C, Johnson D et al. Prognostic value of tumour "budding" in patients with colorectal cancer. Dis. Colon Rectum 1993 36 627 635.
16. Doki Y, Shiozaki H, Tahara H et al. Correlation between E-cadherin expression and invasiveness in vitro in a human esophageal cancer cell line. Cancer Res. 1993 53 3421 3426.
17. Torres CM, Wang HH, Turner JR et al. Pathologic prognostic factors in esophageal squamous cell carcinoma: a follow-up study of 74 patients with or without preoperative chemoradiation therapy. Mod. Pathol. 1999 12 961 968.
18. Ueno H, Price AB, Wilkinson KH et al. A new prognostic staging system for rectal cancer. Ann. Surg. 2004 240 832 839.